| Literature DB >> 25537360 |
Marina Mora1, Corrado Angelini2, Fabrizia Bignami3, Anne-Mary Bodin4, Marco Crimi5, Jeanne-Hélène Di Donato6, Alex Felice7, Cécile Jaeger8, Veronika Karcagi9, Yann LeCam4, Stephen Lynn10, Marija Meznaric11, Maurizio Moggio12, Lucia Monaco5, Luisa Politano13, Manuel Posada de la Paz14, Safaa Saker15, Peter Schneiderat16, Monica Ensini10, Barbara Garavaglia17, David Gurwitz18, Diana Johnson19, Francesco Muntoni19, Jack Puymirat20, Mojgan Reza10, Thomas Voit21, Chiara Baldo22, Franca Dagna Bricarelli23, Stefano Goldwurm24, Giuseppe Merla25, Elena Pegoraro26, Alessandra Renieri27, Kurt Zatloukal28, Mirella Filocamo29, Hanns Lochmüller10.
Abstract
The EuroBioBank (EBB) network (www.eurobiobank.org) is the first operating network of biobanks in Europe to provide human DNA, cell and tissue samples as a service to the scientific community conducting research on rare diseases (RDs). The EBB was established in 2001 to facilitate access to RD biospecimens and associated data; it obtained funding from the European Commission in 2002 (5th framework programme) and started operation in 2003. The set-up phase, during the EC funding period 2003-2006, established the basis for running the network; the following consolidation phase has seen the growth of the network through the joining of new partners, better network cohesion, improved coordination of activities, and the development of a quality-control system. During this phase the network participated in the EC-funded TREAT-NMD programme and was involved in planning of the European Biobanking and Biomolecular Resources Research Infrastructure. Recently, EBB became a partner of RD-Connect, an FP7 EU programme aimed at linking RD biobanks, registries, and bioinformatics data. Within RD-Connect, EBB contributes expertise, promotes high professional standards, and best practices in RD biobanking, is implementing integration with RD patient registries and 'omics' data, thus challenging the fragmentation of international cooperation on the field.Entities:
Mesh:
Year: 2014 PMID: 25537360 PMCID: PMC4538193 DOI: 10.1038/ejhg.2014.272
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246